PierianDx Acquires Tute Genomics

By Bio-IT World Staff

October 12, 2016 PierianDx today announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT, further increasing consolidation in the genomics space. Tute Genomics acquired Knome last November.

“This type of consolidation is exactly what the industry needs to bring to market the most unified workflow solution for genomic testing,” said Jeffrey Ries Vice President of Healthbox, a Tute investor.

PierianDx’s Clinical Genomicist Workspace (CGW), a cloud-based software platform for somatic cancer, will be enhanced through the addition of Tute Genomics’ constitutional and exome testing capabilities. The integrated offering will provide a single clinical platform for best in class clinical workflow support of somatic cancer and constitutional testing.  PierianDx plans to maintain the Tute Genomics solution until the platforms are fully integrated into CGW 6.0 in the spring of 2017.

As part of the transaction, Reid Robison, CEO of Tute, will join the PierianDx Board of Directors. In addition, GenomeWeb reported, Tute Co-Founder and President Kai Wang will join the advisory board at PierianDx. Tute COO Andy Olson and Vice President of Product Development Bryce Daines will immediately relocate to St. Louis. PierianDx will maintain a development team in Provo, Utah.